BAY 94-8862, Placebo to Finerenone 10 film-coated tablets, Placebo to BAY 948862, BAY 948862, Placebo to Finerenone 20 film-coated tablets, Finerenone
19920
Phase 3 small_molecule active
Quick answer
BAY 94-8862, Placebo to Finerenone 10 film-coated tablets, Placebo to BAY 948862, BAY 948862, Placebo to Finerenone 20 film-coated tablets, Finerenone for Proteinuria, Chronic kidney disease is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Proteinuria, Chronic kidney disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active